FLGC vs. GLTO, BIVI, KALA, NRBO, GLYC, NNVC, APM, ORGS, TCRT, and NRSN
Should you be buying Flora Growth stock or one of its competitors? The main competitors of Flora Growth include Galecto (GLTO), BioVie (BIVI), KALA BIO (KALA), NeuroBo Pharmaceuticals (NRBO), GlycoMimetics (GLYC), NanoViricides (NNVC), Aptorum Group (APM), Orgenesis (ORGS), Alaunos Therapeutics (TCRT), and NeuroSense Therapeutics (NRSN). These companies are all part of the "pharmaceutical preparations" industry.
Flora Growth (NASDAQ:FLGC) and Galecto (NASDAQ:GLTO) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, dividends, earnings, profitability, community ranking, risk and valuation.
36.0% of Flora Growth shares are held by institutional investors. Comparatively, 14.2% of Galecto shares are held by institutional investors. 17.6% of Flora Growth shares are held by insiders. Comparatively, 12.1% of Galecto shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Galecto has lower revenue, but higher earnings than Flora Growth.
Flora Growth has a beta of 2, indicating that its share price is 100% more volatile than the S&P 500. Comparatively, Galecto has a beta of 1.26, indicating that its share price is 26% more volatile than the S&P 500.
Galecto has a net margin of 0.00% compared to Flora Growth's net margin of -75.95%. Galecto's return on equity of -87.11% beat Flora Growth's return on equity.
Flora Growth currently has a consensus target price of $6.00, suggesting a potential upside of 358.02%. Galecto has a consensus target price of $5.33, suggesting a potential upside of 758.69%. Given Galecto's higher probable upside, analysts plainly believe Galecto is more favorable than Flora Growth.
Galecto received 16 more outperform votes than Flora Growth when rated by MarketBeat users. However, 60.87% of users gave Flora Growth an outperform vote while only 58.82% of users gave Galecto an outperform vote.
In the previous week, Flora Growth had 10 more articles in the media than Galecto. MarketBeat recorded 10 mentions for Flora Growth and 0 mentions for Galecto. Flora Growth's average media sentiment score of 0.26 beat Galecto's score of 0.00 indicating that Flora Growth is being referred to more favorably in the media.
Summary
Flora Growth beats Galecto on 9 of the 14 factors compared between the two stocks.
Get Flora Growth News Delivered to You Automatically
Sign up to receive the latest news and ratings for FLGC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding FLGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Flora Growth Competitors List
Related Companies and Tools
